The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.
Moderna’s Shift to Cancer Company Lifts Stock Up 177%
A portal for worldwide news
The company’s fortunes cratered as demand for Covid-19 vaccines plummeted. But it was busy working on something else.